首页> 美国卫生研究院文献>Frontiers in Oncology >Radioembolization of Hepatic Lesions from a Radiobiology and Dosimetric Perspective
【2h】

Radioembolization of Hepatic Lesions from a Radiobiology and Dosimetric Perspective

机译:从放射生物学和剂量学角度看肝病变的放射栓塞

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Radioembolization (RE) of liver cancer with 90Y-microspheres has been applied in the last two decades with notable responses and acceptable toxicity. Two types of microspheres are available, glass and resin, the main difference being the activity/sphere. Generally, administered activities are established by empirical methods and differ for the two types. Treatment planning based on dosimetry is a prerogative of few centers, but has notably gained interest, with evidence of predictive power of dosimetry on toxicity, lesion response, and overall survival (OS). Radiobiological correlations between absorbed doses and toxicity to organs at risk, and tumor response, have been obtained in many clinical studies. Dosimetry methods have evolved from the macroscopic approach at the organ level to voxel analysis, providing absorbed dose spatial distributions and dose–volume histograms (DVH). The well-known effects of the external beam radiation therapy (EBRT), such as the volume effect, underlying disease influence, cumulative damage in parallel organs, and different tolerability of re-treatment, have been observed also in RE, identifying in EBRT a foremost reference to compare with. The radiobiological models – normal tissue complication probability and tumor control probability – and/or the style (DVH concepts) used in EBRT are introduced in RE. Moreover, attention has been paid to the intrinsic different activity distribution of resin and glass spheres at the microscopic scale, with dosimetric and radiobiological consequences. Dedicated studies and mathematical models have developed this issue and explain some clinical evidences, e.g., the shift of dose to higher toxicity thresholds using glass as compared to resin spheres. This paper offers a comprehensive review of the literature incident to dosimetry and radiobiological issues in RE, with the aim to summarize the results and to identify the most useful methods and information that should accompany future studies.
机译:在过去的20年中,具有 90 Y微球的肝癌的放射栓塞(RE)已被应用,其显着的反应和可接受的毒性。可以使用两种类型的微球:玻璃和树脂,主要区别是活性/球。通常,所管理的活动是通过经验方法确定的,并且对于这两种类型是不同的。基于剂量测定的治疗计划是少数几个中心的特权,但随着剂量测定对毒性,病变反应和总生存期(OS)的预测能力的证明,该计划已引起广泛关注。在许多临床研究中已经获得了吸收剂量与对处于危险中的器官的毒性以及肿瘤反应之间的放射生物学相关性。剂量学方法已经从器官级别的宏观方法发展到体素分析,提供了吸收的剂量空间分布和剂量-体积直方图(DVH)。在RE中也观察到了外部束放射疗法(EBRT)的众所周知的效应,例如体积效应,潜在的疾病影响,平行器官的累积损伤以及不同的再耐受性,从而确定了EBRT要比较的首要参考。 RE中引入了放射生物学模型-正常组织并发症概率和肿瘤控制概率-和/或EBRT中使用的样式(DVH概念)。此外,已经注意到树脂和玻璃球在微观尺度上固有的不同活性分布,具有剂量学和放射生物学的后果。专门的研究和数学模型已经解决了这个问题,并解释了一些临床证据,例如,与树脂球相比,使用玻璃将剂量转移到更高的毒性阈值。本文对RE中剂量学和放射生物学问题的文献进行了全面的综述,目的是总结结果并确定未来研究中最有用的方法和信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号